New York, NY, United States of America

Jutta M Loeffler

This inventor holds 1 USPTO granted patent. Top assignee: The Rockefeller University. Active years: 2009.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jutta M Loeffler: Innovator in Bacterial Treatment

Introduction

Jutta M Loeffler is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of microbiology, particularly in the treatment of bacterial infections. Her innovative work focuses on methods and compositions that target bacteria and spores, providing new avenues for medical treatment.

Latest Patents

Jutta M Loeffler holds 1 patent related to her research. The patent discloses methods, compositions, and articles of manufacture that are useful for treating bacteria and spores, as well as related conditions. It also includes methods for identifying a phage-associated lytic enzyme that can rapidly kill bacteria. This groundbreaking work has implications for the treatment of infections and the management of bacterial populations.

Career Highlights

Loeffler is affiliated with The Rockefeller University, where she conducts her research. Her work has garnered attention for its potential to revolutionize how bacterial infections are treated. She is recognized for her dedication to advancing scientific knowledge and improving public health.

Collaborations

Some of her notable coworkers include Vincent A Fischetti and Daniel Craig Nelson. Their collaborative efforts contribute to the innovative research being conducted at The Rockefeller University.

Conclusion

Jutta M Loeffler's contributions to the field of bacterial treatment highlight her role as a leading inventor. Her work not only addresses critical health challenges but also paves the way for future innovations in microbiology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…